Sign In
Buy RNA
$11.35
-0.110 (-0.96%)
At Close: Jul 31, 2026
Harbor Small Cap Growth Fund Q4 2025 Portfolio Performance
10:30pm, Thursday, 29'th Jan 2026
From a sector perspective, strength within Industrials and Information Technology offset relative weakness in Health Care. The October earnings report reinforced confidence in Comfort Systems' ability
BOULDER, CO / ACCESS Newswire / January 28, 2026 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypoc
Avidity Biosciences (NASDAQ:RNA) Insider Sells $212,206.05 in Stock
05:38am, Monday, 26'th Jan 2026
Avidity Biosciences, Inc. (NASDAQ: RNA - Get Free Report) insider Teresa Mccarthy sold 2,929 shares of the business's stock in a transaction on Wednesday, January 21st. The shares were sold at an aver
Steven George Hughes Sells 4,895 Shares of Avidity Biosciences (NASDAQ:RNA) Stock
05:54am, Sunday, 25'th Jan 2026
Avidity Biosciences, Inc. (NASDAQ: RNA - Get Free Report) insider Steven George Hughes sold 4,895 shares of the business's stock in a transaction that occurred on Wednesday, January 21st. The shares w
Michael Maclean Sells 4,542 Shares of Avidity Biosciences (NASDAQ:RNA) Stock
05:54am, Sunday, 25'th Jan 2026
Avidity Biosciences, Inc. (NASDAQ: RNA - Get Free Report) CFO Michael Maclean sold 4,542 shares of the firm's stock in a transaction that occurred on Wednesday, January 21st. The stock was sold at an
W. Michael Flanagan Sells 6,534 Shares of Avidity Biosciences (NASDAQ:RNA) Stock
05:54am, Sunday, 25'th Jan 2026
Avidity Biosciences, Inc. (NASDAQ: RNA - Get Free Report) insider W. Michael Flanagan sold 6,534 shares of Avidity Biosciences stock in a transaction that occurred on Wednesday, January 21st. The shar
Pharma sector doubles down on AI amid hopes of slashing costs, timelines
11:35am, Thursday, 15'th Jan 2026
Pharmaceutical companies are increasingly turning to artificial intelligence to accelerate R&D, betting on new modeling tools and automated labs to unlock efficiency gains across their pipeline.
Avidity Biosciences, Inc. (NASDAQ:RNA) Receives Consensus Rating of “Hold” from Brokerages
02:10am, Monday, 12'th Jan 2026
Shares of Avidity Biosciences, Inc. (NASDAQ: RNA - Get Free Report) have earned a consensus recommendation of "Hold" from the twenty-three brokerages that are currently covering the firm, Marketbeat R
John Moriarty Sells 2,374 Shares of Avidity Biosciences (NASDAQ:RNA) Stock
06:24am, Sunday, 11'th Jan 2026
Avidity Biosciences, Inc. (NASDAQ: RNA - Get Free Report) insider John Moriarty sold 2,374 shares of the business's stock in a transaction dated Wednesday, January 7th. The stock was sold at an averag
Steven George Hughes Sells 2,373 Shares of Avidity Biosciences (NASDAQ:RNA) Stock
06:24am, Sunday, 11'th Jan 2026
Avidity Biosciences, Inc. (NASDAQ: RNA - Get Free Report) insider Steven George Hughes sold 2,373 shares of the business's stock in a transaction on Wednesday, January 7th. The shares were sold at an
Michael Maclean Sells 1,974 Shares of Avidity Biosciences (NASDAQ:RNA) Stock
06:24am, Sunday, 11'th Jan 2026
Avidity Biosciences, Inc. (NASDAQ: RNA - Get Free Report) CFO Michael Maclean sold 1,974 shares of the stock in a transaction that occurred on Wednesday, January 7th. The stock was sold at an average
W. Michael Flanagan Sells 2,373 Shares of Avidity Biosciences (NASDAQ:RNA) Stock
06:24am, Sunday, 11'th Jan 2026
Avidity Biosciences, Inc. (NASDAQ: RNA - Get Free Report) insider W. Michael Flanagan sold 2,373 shares of Avidity Biosciences stock in a transaction dated Wednesday, January 7th. The stock was sold a
Charles Calderaro III Sells 3,727 Shares of Avidity Biosciences (NASDAQ:RNA) Stock
04:56am, Sunday, 11'th Jan 2026
Avidity Biosciences, Inc. (NASDAQ: RNA - Get Free Report) insider Charles Calderaro III sold 3,727 shares of the firm's stock in a transaction dated Wednesday, January 7th. The stock was sold at an av
Sarah Boyce Sells 8,576 Shares of Avidity Biosciences (NASDAQ:RNA) Stock
04:56am, Sunday, 11'th Jan 2026
Avidity Biosciences, Inc. (NASDAQ: RNA - Get Free Report) CEO Sarah Boyce sold 8,576 shares of the company's stock in a transaction dated Wednesday, January 7th. The stock was sold at an average price
Avidity Biosciences (NASDAQ:RNA) Stock Crosses Above Fifty Day Moving Average – Here’s Why
05:12am, Tuesday, 06'th Jan 2026
Avidity Biosciences, Inc. (NASDAQ: RNA - Get Free Report) crossed above its fifty day moving average during trading on Monday. The stock has a fifty day moving average of $71.20 and traded as high as
